Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2014 (2014), Article ID 780686, 9 pages
http://dx.doi.org/10.1155/2014/780686
Research Article

Sm:HAp Nanopowders Present Antibacterial Activity against Enterococcus faecalis

1National Institute of Materials Physics, P.O. Box MG 07, 76900 Bucharest, Romania
2Faculty of Physics, University of Bucharest, 405 Atomistilor, P.O. Box MG-1, 077125 Bucharest, Romania

Received 22 January 2014; Accepted 24 February 2014; Published 17 April 2014

Academic Editor: Necdet Aslan

Copyright © 2014 Carmen Steluta Ciobanu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Hao, Y. Liu, S. Zhou, Z. Li, and X. Deng, “Investigation of nanocomposites based on semi-interpenetrating network of [L-poly (ε-caprolactone)]/[net-poly (ε-caprolactone)] and hydroxyapatite nanocrystals,” Biomaterials, vol. 24, no. 9, pp. 1531–1539, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. C. R. Safinya and L. Addadi, “Biomaterials,” Current Opinion in Solid State and Materials Science, vol. 2, no. 3, pp. 325–329, 1997. View at Google Scholar · View at Scopus
  3. A. Groza, “Review of the processes identified during the polymerization of organic and organosilicon liquid films in atmospheric pressure air corona discharges,” Romanian Reports in Physics, vol. 64, pp. 1227–1242, 2012. View at Google Scholar
  4. Y. J. Han, S. C. J. Loo, N. T. Phung, F. Boey, and J. Ma, “Controlled size and morphology of EDTMP-doped hydroxyapatite nanoparticles as model for 153Samarium-EDTMP doping,” Journal of Materials Science: Materials in Medicine, vol. 19, no. 9, pp. 2993–3003, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. D. A. Wahl and J. T. Czernuszka, “Collagen-hydroxyapatite composites for hard tissue repair,” European Cells and Materials, vol. 11, pp. 43–56, 2006. View at Google Scholar · View at Scopus
  6. J. Dumbleton and M. T. Manley, “Hydroxyapatite-coated prostheses in total hip and knee arthroplasty,” Journal of Bone and Joint Surgery A, vol. 86, no. 11, pp. 2526–2540, 2004. View at Google Scholar · View at Scopus
  7. P. Budrugeac, V. Trandafir, and M. G. Albu, “The effect of the hydration degree on the hydrothermal and thermo-oxidative stability of some collageneous matrices,” Journal of Thermal Analysis and Calorimetry, vol. 72, no. 2, pp. 581–585, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. M. V. Ghica, M. G. Albu, M. Leca, L. Popa, and S. T. Moisescu, “Design and optimization of some collagen-minocycline based hydrogels potentially applicable for the treatment of cutaneous wound infections,” Pharmazie, vol. 66, no. 11, pp. 853–861, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. J. S. Grimes, T. J. Bocklage, and J. D. Pitcher, “Collagen and biphasic calcium phosphate bone graft in large osseous defects,” Orthopedics, vol. 29, no. 2, pp. 145–148, 2006. View at Google Scholar · View at Scopus
  10. W. Paul and C. P. Sharma, “Ceramic drug delivery: a perspective,” Journal of Biomaterials Applications, vol. 17, no. 4, pp. 253–264, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Matsumoto, M. Okazaki, M. Inoue et al., “Hydroxyapatite particles as a controlled release carrier of protein,” Biomaterials, vol. 25, no. 17, pp. 3807–3812, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Uchida, Y. Shinto, N. Araki, and K. Ono, “Slow release of anticancer drugs from porous calcium hydroxyapatite ceramic,” Journal of Orthopaedic Research, vol. 10, no. 3, pp. 440–445, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Shinto, A. Uchida, F. Korkusuz, N. Araki, and K. Ono, “Calcium hydroxyapatite ceramic used as a delivery system for antibiotics,” Journal of Bone and Joint Surgery B, vol. 74, no. 4, pp. 600–604, 1992. View at Google Scholar · View at Scopus
  14. M. Itokazu, W. Yang, T. Aoki, A. Ohara, and N. Kato, “Synthesis of antibiotic-loaded interporous hydroxyapatite blocks by vacuum method and in vitro drug release testing,” Biomaterials, vol. 19, no. 7–9, pp. 817–819, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Barroug and M. J. Glimcher, “Hydroxyapatite crystals as a local delivery system for cisplatin: adsorption and release of cisplatin in vitro,” Journal of Orthopaedic Research, vol. 20, no. 2, pp. 274–280, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Gorbunoff, “Protein chromatography on hydroxyapatite columns,” Methods in Enzymology, vol. 117, pp. 370–380, 1985. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Doonan, “Chromatography on hydroxyapatite,” Methods in Molecular Biology, vol. 244, pp. 191–194, 2004. View at Google Scholar · View at Scopus
  18. M. Vallet-Regí, “Ceramics for medical applications,” Journal of the Chemical Society, vol. 2, pp. 97–108, 2001. View at Google Scholar · View at Scopus
  19. L. Hermansson, L. Kraft, and H. Engqvist, “Chemically bonded ceramics as biomaterials,” Key Engineering Materials, vol. 247, pp. 437–442, 2003. View at Google Scholar · View at Scopus
  20. T. Kokubo, H. Kim, and M. Kawashita, “Novel bioactive materials with different mechanical properties,” Biomaterials, vol. 24, no. 13, pp. 2161–2175, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Shirkhanzadeh, “Microneedles coated with porous calcium phosphate ceramics: effective vehicles for transdermal delivery of solid trehalose,” Journal of Materials Science: Materials in Medicine, vol. 16, no. 1, pp. 37–45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Shigeru, T. Oku, and S. Takagi, “Hydraulic property of hydroxyapatite thermal decomposition product and its application as biomaterial,” Journal of the Ceramic Society of Japan. International Edition, vol. 97, pp. 96–101, 1989. View at Google Scholar
  23. M. Jarcho, C. H. Bolen, M. B. Thomas, J. Bobick, J. F. Kay, and R. H. Doremus, “Hydroxylapatite synthesis and characterization in dense polycrystalline form,” Journal of Materials Science, vol. 11, no. 11, pp. 2027–2035, 1976. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Coelho, N. S. Hussain, P. S. Gomes et al., “Development and characterization of lanthanides doped hydroxyapatite composites for bone tissue application,” in Current Trends on Glass and Ceramic Materials, pp. 87–115, Scopus, 2013. View at Google Scholar
  25. D. Veljović, R. Jančić-Hajneman, I. Balać et al., “The effect of the shape and size of the pores on the mechanical properties of porous HAP-based bioceramics,” Ceramics International, vol. 37, no. 2, pp. 471–479, 2011. View at Google Scholar
  26. T. Kokubo, Bioceramics and Their Clinical Applications, Woodhead Publishing Limited and CRC Press, 2008.
  27. A. Aissa, M. Debbabi, M. Gruselle et al., “Sorption of tartrate ions to lanthanum (III)-modified calcium fluor- and hydroxyapatite,” Journal of Colloid and Interface Science, vol. 330, no. 1, pp. 20–28, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. S. P. Fricker, “The therapeutic application of lanthanides,” Chemical Society Reviews, vol. 35, no. 6, pp. 524–533, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. K. H. Thompson and C. Orvig, “Lanthanide compounds for therapeutic and diagnostic applications,” Chemical Society Reviews, vol. 35, no. 6, p. 499, 2006. View at Google Scholar
  30. T. Matsuda, C. Yamanaka, and M. Ikeya, “ESR study of Gd3+ and Mn2+ ions sorbed on hydroxyapatite,” Applied Radiation and Isotopes, vol. 62, no. 2, pp. 353–357, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Fan, S. Huang, J. Jiang et al., “Luminescent, mesoporous, and bioactive europium-doped calcium silicate (MCS: Eu3+) as a drug carrier,” Journal of Colloid and Interface Science, vol. 357, no. 2, pp. 280–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Neumeier, L. A. Hails, S. A. Davis, S. Mann, and M. Epple, “Synthesis of fluorescent core-shell hydroxyapatite nanoparticles,” Journal of Materials Chemistry, vol. 21, no. 4, pp. 1250–1254, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. I. A. Appavoo and Y. Zhang, “Upconverting fluorescent nanoparticles for biological applications,” in Emerging Nanotechnologies for Manufacturing, A. Waqar and J. J. Mark, Eds., pp. 159–175, William Andrew, Boston, Mass, USA, 2010. View at Google Scholar
  34. J. H. Turner, P. G. Claringbold, E. L. Hetherington, P. Sorby, and A. A. Martindale, “A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases,” Journal of Clinical Oncology, vol. 7, no. 12, pp. 1926–1931, 1989. View at Google Scholar · View at Scopus
  35. J. H. Turner and P. G. Claringbold, “A phase II study of treatment of painful multifocal skeletal metastases with single and repeated dose samarium-153 ethylenediaminetetramethylene phosphonate,” European Journal of Cancer, vol. 27, no. 9, pp. 1084–1086, 1991. View at Publisher · View at Google Scholar · View at Scopus
  36. J. F. Eary, C. Collins, M. Stabin et al., “Samarium-153-EDTMP biodistribution and dosimetry estimation,” Journal of Nuclear Medicine, vol. 34, no. 7, pp. 1031–1036, 1993. View at Google Scholar · View at Scopus
  37. D. A. Podoloff, L. P. Kasi, E. E. Kim, F. Fossella, and V. A. Bhadkamar, “Evaluation of Sm-153-EDTMP as a bone imaging agent during a therapeutical trial,” Journal of Nuclear Medicine, vol. 32, p. A918, 1991. View at Google Scholar
  38. M. F. dos Santos, R. N. V. Furtado, M. S. Konai, M. L. V. Castiglioni, R. R. Marchetti, and J. Natour, “Effectiveness of radiation synovectomy with samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled randomized double-blind trial,” Clinics, vol. 64, no. 12, pp. 1187–1193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. E. K. O'Duffy, F. J. Oliver, S. J. Chatters et al., “Chromosomal analysis of peripheral lymphocytes of patients before and after radiation synovectomy with samarium-153 particulate hydroxyapatite,” Rheumatology, vol. 38, no. 4, pp. 316–320, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. E. K. O'Duffy, G. P. R. Clunie, D. Lui, J. C. W. Edwards, and P. J. Ell, “Double blind glucocorticoid controlled trial of samarium-153 particulate hydroxyapatite radiation synovectomy for chronic knee synovitis,” Annals of the Rheumatic Diseases, vol. 58, no. 9, pp. 554–558, 1999. View at Google Scholar · View at Scopus
  41. P. Pusuwan, P. Asavatanabodee, and P. Chaudakshetrin, “Radiation synovectomy with Samarium-153 particulate hydroxyapatite: a preliminary report,” in Proceedings of the International Atomic Energy Agency-Publications-Iaea SR, 209, SR-209/52 Therapeutic Applications of Radiopharmaceuticals International Seminar, Therapeutic Applications of Radiopharmaceuticals, International Atomic Energy, Agency, 1999.
  42. G. Clunie, D. Lui, I. Cullum, J. C. W. Edwards, and P. J. Ell, “Samarium-153-particulate hydroxyapatite radiation synovectomy: biodistribution data for chronic knee synovitis,” Journal of Nuclear Medicine, vol. 36, no. 1, pp. 51–57, 1995. View at Google Scholar · View at Scopus
  43. International Consensus on Periprosthetic Joint Infection, The Musculoskeletal Infection Society, http://www.msis-na.org/international-consensus/.
  44. M. Chinol, S. Vallabhajosula, S. J. Goldsmith et al., “Chemistry and biological behavior of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy,” Journal of Nuclear Medicine, vol. 34, no. 9, pp. 1536–1542, 1993. View at Google Scholar · View at Scopus
  45. J. U. Calegaro, J. C. de Paula, J. S. C. de Almeida, and L. A. Casulari, “Clinical evaluation after 1 year of 153-samarium hydroxyapatite synovectomy in patients with haemophilic arthropathy,” Haemophilia, vol. 15, no. 1, pp. 240–246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Wang, R. Hu, D. Jiang, P. Zhang, Q. Lin, and Y. Wang, “Synthesis, crystal structure, interaction with BSA and antibacterial activity of La(III) and Sm(III) complexes with enrofloxacin,” Journal of Fluorescence, vol. 21, no. 2, pp. 813–823, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. F. Zhao, H. B. Chu, F. Bai et al., “Synthesis, crystal structure, luminescent property and antibacterial activity of lanthanide ternary complexes with 2, 4, 6-tri(2-pyridyl)-s-triazine,” Journal of Organometallic Chemistry, vol. 716, pp. 167–174, 2012. View at Google Scholar
  48. A. M. Ajlouni, Z. A. Taha, W. Al Momani, A. K. Hijazi, and M. Ebqa'ai, “Synthesis, characterization, biological activities, and luminescent properties of lanthanide complexes with N,N′-bis(2-hydroxy-1-naphthylidene)-1,6-hexadiimine,” Inorganica Chimica Acta, vol. 388, pp. 120–126, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Mohanan, B. S. Kumari, and G. Rijulal, “Microwave assisted synthesis, spectroscopic, thermal, and antifungal studies of some lanthanide(III) complexes with a heterocyclic bishydrazone,” Journal of Rare Earths, vol. 26, no. 1, pp. 16–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Lutterotti, “Total pattern fitting for the combined size-strain-stress-texture determination in thin film diffraction,” Nuclear Instruments and Methods in Physics Research B: Beam Interactions with Materials and Atoms, vol. 268, no. 3-4, pp. 334–340, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. N. C. Popa, “The (hkl) dependence of diffraction-line broadening caused by strain and size for all Laue groups in Rietveld refinement,” Journal of Applied Crystallography, vol. 31, no. 2, pp. 176–180, 1998. View at Google Scholar · View at Scopus
  52. C. S. Ciobanu, S. L. Iconaru, F. Massuyeau, L. V. Constantin, A. Costescu, and D. Predoi, “Synthesis, structure, and luminescent properties of europium-doped hydroxyapatite nanocrystalline powders,” Journal Nanomaterials, vol. 2012, Article ID 942801, 9 pages, 2012. View at Publisher · View at Google Scholar
  53. M. Markovic, B. O. Fowler, and M. S. Tung, “Preparation and comprehensive characterization of a calcium hydroxyapatite reference material,” Journal of Research of the National Institute of Standards and Technology, vol. 109, no. 6, pp. 553–568, 2004. View at Google Scholar · View at Scopus
  54. W. Jastrzbski, M. Sitarz, M. Rokita, and K. Bułat, “Infrared spectroscopy of different phosphates structures,” Spectrochimica Acta A: Molecular and Biomolecular Spectroscopy, vol. 79, no. 4, pp. 722–727, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. J. C. Elliott, Structure and Chemistry of the Apatites and Other Calcium, Orthophosphates, Elsevier Science, Amsterdam, The Netherlands, 1994.
  56. R. Z. LeGeros, Calcium Phosphates in Oral Biology and Medicine. Monographs in Oral Sciences, Karger, Basel, Switzerland, 1991.
  57. C. S. Ciobanu, E. Andronescu, B. S. Vasile, C. M. Valsangiacom, R. V. Ghita, and D. Predoi, “Looking for new synthesis of hydroxyapatite doped with europium,” Optoelectronics and Advanced Materials, Rapid Communications, vol. 4, no. 10, pp. 1515–1519, 2010. View at Google Scholar · View at Scopus
  58. X. Bai, K. More, C. M. Rouleau, and A. Rabiei, “Functionally graded hydroxyapatite coatings doped with antibacterial components,” Acta Biomaterialia, vol. 6, no. 6, pp. 2264–2273, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Nakamoto, Infrared and Raman Spectra of Inorganic and Coordination Compounds, Wiley, New York, NY, USA, 1978.
  60. R. Z. LeGeros, G. Bonel, and R. Legros, “Types of “H2O” in human enamel and in precipitated apatites,” Calcified Tissue Research, vol. 26, no. 1, pp. 111–118, 1978. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Eriksson, Y. Liu, J. Hu, L. Gao, M. Nygren, and Z. Shen, “Transparent hydroxyapatite ceramics with nanograin structure prepared by high pressure spark plasma sintering at the minimized sintering temperature,” Journal of the European Ceramic Society, vol. 31, no. 9, pp. 1533–1540, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. I. Cacciotti and A. Bianco, “High thermally stable Mg-substituted tricalcium phosphate via precipitation,” Ceramics International, vol. 37, no. 1, pp. 127–137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. E. I. Get'man, S. N. Loboda, T. V. Tkachenko, N. V. Yablochkova, and K. A. Chebyshev, “Isomorphous substitution of samarium and gadolinium for calcium in hydroxyapatite structure,” Russian Journal of Inorganic Chemistry, vol. 55, no. 3, pp. 333–338, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. M. P. Casaletto, S. Kaciulis, G. Mattogno, A. Mezzi, L. Ambrosio, and F. Branda, “XPS characterization of biocompatible hydroxyapatite-polymer coatings,” Surface and Interface Analysis, vol. 34, no. 1, pp. 45–49, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. C. S. Ciobanu, S. L. Iconaru, M. C. Chifriuc, A. Costescu, P. le Coustumer, and D. Predoi, “Synthesis and antimicrobial activity of silver-doped hydroxyapatite nanoparticles,” BioMed Research International, vol. 2013, Article ID 916218, 10 pages, 2013. View at Publisher · View at Google Scholar
  66. Y. Kim, H. Schleg, K. Kim, J. T. S. Irvine, and J. H. Kim, “X-ray photoelectron spectroscopy of Sm-doped layered perovskite forintermediate temperature-operating solid oxide fuel cell,” Applied Surface Science, vol. 288, pp. 695–701, 2014. View at Google Scholar
  67. C. S. Ciobanu, F. Massuyeau, L. V. Constantin, and D. Predoi, “Structural and physical properties of antibacterial Ag-doped nano-hydroxyapatite synthesized at 100°C,” Nanoscale Research Letters, vol. 6, article 613, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. O. Dubok, O. Shynkaruk, and E. Buzaneva, “Lanthanides oxides usage to increase radiopaque of bioactive ceramics,” Functional Materials, vol. 20, no. 2, pp. 172–178, 2013. View at Google Scholar
  69. I. G. Sia, E. F. Berbari, and A. W. Karchmer, “Prosthetic joint infections,” Infectious Disease Clinics of North America, vol. 19, no. 4, pp. 885–914, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. P. Hsieh, M. S. Lee, K. Hsu, Y. Chang, H. Shin, and S. W. Ueng, “Gram-negative prosthetic joint infections: risk factors and outcome of treatment,” Clinical Infectious Diseases, vol. 49, no. 7, pp. 1036–1043, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. I. Uçkay and L. Bernard, “Gram-negative versus gram-positive prosthetic joint infections,” Clinical Infectious Diseases, vol. 50, no. 5, p. 795, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. B. Zmistowski, C. J. Fedorka, E. Sheehan, G. Deirmengian, M. S. Austin, and J. Parvizi, “Prosthetic joint infection caused by gram-negative organisms,” Journal of Arthroplasty, vol. 26, no. 6, pp. 104–108, 2011. View at Publisher · View at Google Scholar · View at Scopus